Last reviewed · How we verify
NCT06963047
Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care
NA trial testing Ultrasound in Postpartum Period in 276 participants. Currently enrolling.
1 May 2026
Quick facts
| Lead sponsor | Holy Family Hospital, Nazareth, Israel |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 276 |
| Start date | 8 May 2025 |
| Primary completion | 1 May 2026 |
| Estimated completion | 1 June 2026 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Ultrasound
- Standard care — full drug profile →
Conditions studied
- Postpartum Period — all drugs for Postpartum Period →
Sponsor
Holy Family Hospital, Nazareth, Israel
Who can join
Adults 18 to 50, female only, with Postpartum Period. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Postpartum hemorrhage and anemia are considered a major health concern due to their impact on maternal morbidity and mortality, quality of life, and maternal cognitive and emotional functioning after delivery, which are particularly important during the critical period of mother-child bonding. Hemoglobin levels in the first 24 hours after delivery do not reflect the lowest point (nadir). The postpartum nadir occurs 48-72 hours after delivery due to the initial redistribution of plasma volume. The aim of this study was to examine whether postpartum ultrasound examination precedes laboratory test results in the diagnosis of anemia due to blood loss after cesarean section.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06963047
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ultrasound
Trials testing the same drug.
- NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
- NCT07505433 — Ultrasound Monitoring of Bone Healing in Ilizarov Bone Transport · not yet recruiting
- NCT07498517 — Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT · Phase 2 · not yet recruiting
- NCT07342790 — Artificial Intelligence Clinical Decision · NA · not yet recruiting
- NCT07169890 — Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris · NA · completed
Other recruiting trials for Postpartum Period
Currently open trials in the same condition.
- NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
- NCT07271953 — The Effect of Motivational Interviewing and Digital Game-Supported Counseling on Postpartum Relapse · NA · recruiting
- NCT07104227 — Effects of Body Mechanics Training on Shoulder-Back Pain and Breastfeeding Ergonomics in Breastfeeding Mothers · NA · active not recruiting
- NCT06762301 — The Effect of Sexual Education-Counseling According to PLISSIT Model of Couples' Sexual Functions During Pregnancy and P · NA · active not recruiting
Other Holy Family Hospital, Nazareth, Israel trials
Trials by the same sponsor.
- NCT06953141 — Ultrasound for Assessment of Intra-Abdominal Blood Loss After Gynecological Surgery · recruiting
- NCT06325007 — Castor Oil Ingestion and Balloon Catheter for Labor Induction in Nulliparous · NA · recruiting
- NCT05481853 — One Anastomosis Gastric Bypass for Severe Obesity in 6,722 Patients: Early Outcomes From the Assuta Surgery Registry · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06963047 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Holy Family Hospital, Nazareth, Israel
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06963047.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing